Despite scholars conducting relevant research, no comprehensive review has yet consolidated the available evidence to draw definitive conclusions
Intravenous glutathione (IV GSH) has received approval from various official drug regulatory agencies to treat specific systemic disorders

The liver is the most important detoxification organs, which contains rich in glutathione (GSH) on the liver function such as synthesis, detoxification, estrogen inactivated protection.It is the first anti-oxidant that the human body is to counteract the damage of free radicals, and the free radical is a contributing factor to the aging and disease.When the liver is damage, such as suffering from all kinds of liver disease, the body will consume large amounts of GSH to help repair the injured liver and detoxification, that cause the body's glutathione are greatly reduced.But this time we need to take some glutathione peptide drugs, is advantageous to the injury of liver to repair itself.Thus, glutathione peptide drugs are suitable for viral hepatitis (hepatitis a and hepatitis b, etc.), alcoholic liver disease,drug-induced liver disease, fatty liver disease ,its a good medicine to protect liver

1 Introduction Plateau environments, defined as geographical regions with elevations surpassing 2,500 m, presenting extreme conditions of low oxygen, low pressure, low temperature, dry air, and strong ultraviolet radiation, which have a significant impact on the human cardiovascular system, respiratory system, metabolic system, and immune system
The difference between a safe, effective experience and a risky, disappointing one often comes down to the quality of the product and the expertise of the team administering it
Res Comm Chem Path Pharmacol 37: 293303